NewEdge Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.2K | Hold |
70
| – | – | ﹤0.01% | 2938 |
|
|
2025
Q1 | $23.2K | Hold |
70
| – | – | ﹤0.01% | 2813 |
|
|
2024
Q4 | $21.6K | Hold |
70
| – | – | ﹤0.01% | 2788 |
|
|
2024
Q3 | $14.9K | Hold |
70
| – | – | ﹤0.01% | 2814 |
|
|
2024
Q2 | $19.6K | Sell |
70
-9
| -11% | -$2.52K | ﹤0.01% | 2631 |
|
|
2024
Q1 | $21.1K | Buy |
79
+70
| +778% | +$18.7K | ﹤0.01% | 2611 |
|
|
2023
Q4 | $2.08K | Hold |
9
| – | – | ﹤0.01% | 3329 |
|
|
2023
Q3 | $1.31K | Sell |
9
-250
| -97% | -$36.5K | ﹤0.01% | 3130 |
|
|
2023
Q2 | $59.8K | Buy |
259
+150
| +138% | +$34.7K | ﹤0.01% | 2033 |
|
|
2023
Q1 | $26.4K | Sell |
109
-62
| -36% | -$15K | ﹤0.01% | 2239 |
|
|
2022
Q4 | $50 | Buy |
+171
| New | +$50 | ﹤0.01% | 3471 |
|
|
2017
Q3 | – | Sell |
-57
| Closed | -$901 | – | 807 |
|
|
2017
Q2 | $901 | Buy |
+57
| New | +$901 | ﹤0.01% | 1355 |
|